In the assessment of 12-month price targets, analysts unveil insights for 10x Genomics, presenting an average target of ...
If you are trying to work out whether 10x Genomics is attractively priced or already reflecting a lot of optimism, the starting point is understanding how its current market value lines up with the ...
Detailed price information for Roche Holding Div RTS (RHHVF) from The Globe and Mail including charting and trades.
Biotech company 10x Genomics (NASDAQ:TXG) in Q2 CY2025, with sales up 12.9% year on year to $172.9 million. On the other hand, next quarter’s revenue guidance of $142 million was less impressive, ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, ...
Genomics announced new multi year collaborations in cancer research with PharosAI, the Cancer Research Institute, and Dana Farber Cancer Institute. The partners plan to use 10x Genomics spatial ...
PLEASANTON, Calif. and SINGAPORE, July 17, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS) ...
Investors usually find it discouraging when an analyst cuts the price target on one of their stocks. In this instance, the cut to this company's shares was rather deep. It wasn't immediately apparent ...
"I am incredibly proud of the tenacity and ingenuity our team displayed throughout 2025," said Serge Saxonov, Co-founder and CEO of 10x Genomics. "While the macro environment was challenging, the team ...
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to ...
PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber Cancer Institute to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results